Winslow Evans & Crocker’s Insys Therapeutics, Inc. INSY Stock Holding History

Winslow Evans & Crocker’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,060	Closed	-$20K	–	1406
2019 Q1	$20K	Hold	4,060	–	–	0.01%	677
2018 Q4	$16K	Hold	4,060	–	–	0.01%	686
2018 Q3	$42K	Hold	4,060	–	–	0.01%	521
2018 Q2	$30K	Hold	4,060	–	–	0.01%	606
2018 Q1	$24.5K	Buy	+4,060	New	+$33.5K	0.01%	608

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Winslow Evans & Crocker's INSY Position: Q2 2019 in Review

Winslow Evans & Crocker sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 4,060 shares — an estimated $20K sold.

Winslow Evans & Crocker first reported a position in INSY in Q1 2018 and held it in 5 quarters. The position peaked at $42K in Q3 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Winslow Evans & Crocker reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Winslow Evans & Crocker sold 4,060 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $20K.
Winslow Evans & Crocker first reported a position in Insys Therapeutics, Inc. in Q1 2018 and held it in 5 quarters.
Winslow Evans & Crocker's Insys Therapeutics, Inc. position peaked at $42K in Q3 2018.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Winslow Evans & Crocker's 13F filing for Q2 2019, filed 19 Jul 2019.